Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Opinion in Anaesthesiology

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ACO.0b013e32833724c3PMID 20124996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutritional status and prognosis in cirrhotic patients.

  2012cited by this paper
• Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review

  2010cited by this paper
• Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis

  2009cited by this paper
• 93 RIFAXIMIN IS EFFECTIVE IN MAINTAINING REMISSION IN HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

  2009cited by this paper
• Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.

  2009cited by this paper
• l‐Ornithine‐l‐aspartate in the management of hepatic encephalopathy: A meta‐analysis

  2009cited by this paper
• An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

  2008cited by this paper
• Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium‐calmodulin kinase II

  2008cited by this paper
• Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy

  2008cited by this paper
• Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis

  2008cited by this paper
• Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure

  2007cited by this paper
• Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis

  2007cited by this paper
• Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions

  2007cited by this paper
• Nutritional status and prognosis in cirrhotic patients

  2006cited by this paper
• Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled Trial

  2006cited by this paper
• Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.

  2006cited by this paper
• Gastrointestinal bleeding: don’t overlook the role of the pancreas

  2005cited by this paper
• Effects of L-carnitine in patients with hepatic encephalopathy.

  2005cited by this paper
• Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.

  2005cited by this paper
• Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study

  2005cited by this paper
• Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy

  2005cited by this paper
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

  2004cited by this paper
• Benzodiazepine receptor antagonists for hepatic encephalopathy.

  2004cited by this paper
• Molecular adsorbent recirculating system for acute and acute‐on‐chronic liver failure: A meta‐analysis

  2004cited by this paper
• Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

  2004cited by this paper
• Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.

  2003cited by this paper
• Oxidative and nitrosative stress in ammonia neurotoxicity

  2003cited by this paper
• Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy.

  2003cited by this paper
• Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

  2003cited by this paper
• Infection and the progression of hepatic encephalopathy in acute liver failure.

  2003cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes

  2001cited by this paper
• Hepatic encephalopathy

  2001cited by this paper
• Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration

  1999cited by this paper
• Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross‐over comparison

  1993cited by this paper

• Insuficiencia hepática aguda

  2025cites this paper
• Insuffisance hépatique aiguë

  2024cites this paper
• Insufficienza epatica acuta

  2024cites this paper
• Perioperative management of liver surgery—review on pathophysiology of liver disease and liver failure

  2018cites this paper
• Probiotics for people with hepatic encephalopathy.

  2017cites this paper
• Small-for-Size Syndrome: Bridging the Gap Between Liver Transplantation and Graft Recovery

  2017cites this paper
• General Anesthesia for the Patient with End-Stage Liver Disease and Post Liver Transplantation

  2017cites this paper
• pH-sensitive microemulsion-based gels for removal of colonic ammonia: a novel preventative oral preparation for hepatic encephalopathy in rats.

  2015cites this paper
• Acute liver failure.

  2014cites this paper
• Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure

  2014cites this paper
• Complications in acute liver failure: managing hepatic encephalopathy and cerebral oedema

  2014cites this paper
• Monitoring and managing hepatic disease in anaesthesia.

  2013cites this paper
• Alcoholism & depression.

  2012cites this paper
• Role of Manganese as Mediator of Central Nervous System: Alteration in Experimental Portal Hypertension

  2012cites this paper
• Anesthetic considerations for the patient with liver disease.

  2012cites this paper
• Routine Postoperative Care After Liver Transplantation

  2012cites this paper
• Chronic Portosystemic Encephalopathy and its Management

  2012cites this paper
• Intensivmedizinisches Management bei Lebererkrankungen im Endstadium (MELD > 30)

  2012cites this paper
• The patient with cirrhosis who presents for non-hepatic surgery

  2011cites this paper
• Gut-Brain Chemokine Changes in Portal Hypertensive Rats

  2011cites this paper
• Insufficienza epatica acuta

  2011cites this paper
• Probiotics for patients with hepatic encephalopathy.

  2011cites this paper
• Insuffisance hépatique aiguë

  2011cites this paper
• Anesthesia for Transplantation

  2011cites this paper
• Insuficiencia hepática aguda

  2011cites this paper
• Identification, Prevention and Management of Risks Associated With Hepatic Encephalopathy -A Review

  2010cites this paper